Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media.
Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy.
Deacetylation of Septin4 by SIRT2 (Silent Mating Type Information Regulation 2 Homolog-2) Mitigates Damaging of Hypertensive Nephropathy.
Zhang Y, Zhang N, Zou Y, Song C, Cao K, Wu B, You S, Lu S, Wang D, Xu J, Huang X, Zhang P, Fan Z, Liu J, Cheng Z, Zhang Z, Kong C, Cao L, Sun Y.
Circ Res. 2023 Mar 3;132(5):601-624. doi: 10.1161/CIRCRESAHA.122.321591. Epub 2023 Feb 14.
Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70.
Costantino VV, Gil Lorenzo AF, Bocanegra V, Vallés PG.
Cells. 2021 Nov 12;10(11):3146. doi: 10.3390/cells10113146.
Natural products: potential treatments for cisplatin-induced nephrotoxicity.
Fang CY, Lou DY, Zhou LQ, Wang JC, Yang B, He QJ, Wang JJ, Weng QJ.
Acta Pharmacol Sin. 2021 Dec;42(12):1951-1969. doi: 10.1038/s41401-021-00620-9. Epub 2021 Mar 9.
Inhibition of ferroptosis ameliorates hypertensive nephropathy through p53/Nrf2/p21 pathway by Taohongsiwu decoction: Based on network pharmacology and experimental validation.
Xie T, Bai Z, Chen Z, Liang H, Liu T, Lam LK, Xu P, Xie P, Chen L, Xiao Y.
J Ethnopharmacol. 2023 Aug 10;312:116506. doi: 10.1016/j.jep.2023.116506. Epub 2023 Apr 21.
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.
Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M.
J Hum Hypertens. 2014 Feb;28(2):74-9. doi: 10.1038/jhh.2013.55. Epub 2013 Jun 27.
OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells.
Wang MY, Yu TX, Wang QY, Han X, Hu X, Ye SJ, Long XH, Wang Y, Zhu H, Luo W, Liang G.
Acta Pharmacol Sin. 2024 Apr;45(4):765-776. doi: 10.1038/s41401-023-01192-6. Epub 2023 Dec 18.
Mechanism of ferroptosis in hypertensive nephropathy.
Chen Y, Wang K, Yang J, Zhang A, Dong X, Zhou Z, Li T, Fan R.
Transl Androl Urol. 2022 May;11(5):617-626. doi: 10.21037/tau-22-276.
B cell-derived anti-beta 2 glycoprotein I antibody mediates hyperhomocysteinemia-aggravated hypertensive glomerular lesions by triggering ferroptosis.
Du X, Ma X, Tan Y, Shao F, Li C, Zhao Y, Miao Y, Han L, Dang G, Song Y, Yang D, Deng Z, Wang Y, Jiang C, Kong W, Feng J, Wang X.
Signal Transduct Target Ther. 2023 Mar 13;8(1):103. doi: 10.1038/s41392-023-01313-x.
VEGFC ameliorates salt-sensitive hypertension and hypertensive nephropathy by inhibiting NLRP3 inflammasome via activating VEGFR3-AMPK dependent autophagy pathway.
Wu Q, Meng W, Zhu B, Chen X, Fu J, Zhao C, Liu G, Luo X, Lv Y, Zhao W, Wang F, Hu S, Zhang S.
Cell Mol Life Sci. 2023 Oct 14;80(11):327. doi: 10.1007/s00018-023-04978-3.
Roles of the mechanosensitive ion channel Piezo1 in the renal podocyte injury of experimental hypertensive nephropathy.
Ogino S, Yoshikawa K, Nagase T, Mikami K, Nagase M.
Hypertens Res. 2024 Mar;47(3):747-759. doi: 10.1038/s41440-023-01536-z. Epub 2023 Dec 25.
